Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.

Autor: Swindells, S.1 sswindells@unmc.edu, Andrade-Villanueva, J.-F.2, Richmond, G. J.3, Rizzardini, G.4, Baumgarten, A.5, Masiá, M.6, Latiff, G.7, Pokrovsky, V.8, Bredeek, F.9, Smith, G.10, Cahn, P.11, Kim, Y.-S.12, Ford, S. L.13, Talarico, C. L.14, Patel, P.14, Chounta, V.15, Crauwels, H.16, Parys, W.16, Vanveggel, S.16, Mrus, J.14
Zdroj: New England Journal of Medicine. 3/19/2020, Vol. 382 Issue 12, p1112-1123. 12p.
Databáze: Academic Search Ultimate